Evaluation and Management of a 25-Year-Old with Fatigue, Depression, Daytime Somnolence, and Mild Leukocytosis
This patient's symptoms are likely multifactorial, but the vitamin D level of 22 ng/mL warrants supplementation given the strong association with fatigue and daytime sleepiness, while the mild leukocytosis with neutrophilia requires evaluation for underlying causes including the depression itself, though routine screening for vitamin D deficiency in asymptomatic adults is not recommended by USPSTF guidelines.
Vitamin D Deficiency Management
Despite USPSTF guidelines stating insufficient evidence for screening asymptomatic adults, this patient is symptomatic with fatigue and excessive daytime sleepiness, making vitamin D supplementation reasonable. 1
Evidence for Treatment in Symptomatic Patients
Vitamin D supplementation significantly improved fatigue in a randomized controlled trial of otherwise healthy persons with vitamin D deficiency (25(OH)D <20 μg/L), with a single 100,000 IU dose producing significant improvement in fatigue scores at 4 weeks compared to placebo (P=0.01). 2
Resolution of excessive daytime sleepiness has been documented in case reports where vitamin D supplementation (50,000 IU weekly) led to complete resolution of hypersomnia within 2 weeks, with Epworth Sleepiness Scale scores dropping from 10/24 to 1/24. 3
The association between vitamin D deficiency and excessive daytime sleepiness is well-established in older adults, with vitamin D deficiency showing an odds ratio of 2.0 (95% CI 1.12-3.55) for excessive daytime sleepiness even after adjusting for multiple confounders. 4
Recommended Supplementation Approach
Initiate vitamin D3 supplementation with either 50,000 IU weekly for 8 weeks or a single dose of 100,000 IU, as both regimens have demonstrated efficacy in symptomatic patients. 3, 2
Reassess symptoms in 2-4 weeks, as clinical improvement in fatigue and daytime sleepiness typically occurs within this timeframe. 3, 2
Recheck 25(OH)D levels after 3 months to ensure adequate repletion (target >30 ng/mL), then transition to maintenance dosing of 1,000-2,000 IU daily. 3
Depression Evaluation
The depression requires comprehensive evaluation as it may contribute to both the fatigue/somnolence and the leukocytosis.
Depression and Vitamin D Connection
Vitamin D deficiency is inversely associated with depression risk, with supplementation showing beneficial effects on depressive symptoms in multiple studies, particularly in younger populations. 5, 6
In early adolescents, vitamin D deficiency was associated with a 50% increased risk for increasing trajectory of depression symptoms (adjusted RR=1.50,95% CI 1.10-2.05). 6
Depression-Specific Workup
Assess depression severity using standardized tools (PHQ-9) to quantify symptoms and guide treatment decisions. 7
Screen for sleep disorders beyond just daytime sleepiness, as depression commonly coexists with insomnia and other sleep disturbances that may require specific management. 7, 8
Consider psychiatric referral if depression is moderate to severe (PHQ-9 ≥15) or if symptoms persist despite vitamin D repletion and initial management. 5
Leukocytosis Evaluation
The mild leukocytosis (WBC 12.4) with absolute neutrophilia (8.4) and lymphocytosis (3.2) requires consideration of multiple etiologies.
Depression-Associated Leukocytosis
Major depression is associated with leukocytosis, neutrophilia, and monocytosis, with severity of depression positively correlating with degree of leukocytosis. 9
This inflammatory response in depression is characterized by increased phagocytic cell populations (neutrophils and monocytes), suggesting an underlying inflammatory process. 9
Recommended Approach to Leukocytosis
Repeat CBC in 2-4 weeks after initiating vitamin D supplementation and addressing depression, as the leukocytosis may resolve with treatment of underlying conditions. 9
If leukocytosis persists or worsens, evaluate for infectious causes (viral syndromes commonly cause lymphocytosis), inflammatory conditions, or medication effects.
No immediate aggressive workup is needed given the mild elevation and absence of other concerning features (no left shift, no immature cells, normal hemoglobin/platelets).
Sleep Disorder Evaluation
Excessive daytime sleepiness requires systematic evaluation beyond just vitamin D deficiency.
Differential Diagnosis Considerations
Distinguish true sleepiness from fatigue, as these require different management approaches—sleepiness involves unintended lapses into sleep, while fatigue is subjective tiredness without sleep propensity. 7
Screen for obstructive sleep apnea with detailed history about snoring, witnessed apneas, morning headaches, and neck circumference measurement, as this is a common cause of daytime somnolence in young adults. 7
Evaluate sleep hygiene and duration, as insufficient sleep syndrome is the most common cause of excessive daytime sleepiness in young adults. 7
When to Pursue Polysomnography
If symptoms persist after 4-6 weeks of vitamin D repletion and depression treatment, consider polysomnography to evaluate for sleep-disordered breathing or other primary sleep disorders. 3, 7
Multiple Sleep Latency Testing (MSLT) should be reserved for cases where narcolepsy or idiopathic hypersomnia is suspected after excluding other causes. 3, 7
Additional Workup Considerations
Complete the evaluation with targeted testing based on clinical presentation.
Thyroid function tests (TSH, free T4) to exclude hypothyroidism as a cause of fatigue, depression, and somnolence.
Complete metabolic panel to assess for electrolyte abnormalities, renal dysfunction, or hepatic issues.
Iron studies and ferritin if any suggestion of iron deficiency, which can cause fatigue independent of anemia.
Screening for other nutritional deficiencies (vitamin B12, folate) is reasonable given the association between multiple micronutrient deficiencies and fatigue/depression. 4
Clinical Pitfalls to Avoid
Do not attribute all symptoms solely to vitamin D deficiency—while supplementation is appropriate, depression and sleep disorders require concurrent evaluation and management. 1, 7
Do not delay depression treatment while waiting for vitamin D repletion, as moderate to severe depression requires prompt intervention regardless of vitamin D status. 5
Do not pursue extensive hematologic workup for mild leukocytosis in the setting of depression without first addressing the underlying psychiatric condition and reassessing. 9
Avoid excessive sun exposure as a treatment for vitamin D deficiency due to skin cancer risk; oral supplementation is safer and more reliable. 1